Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Recruiting 8Completed 5Not yet recruiting 4Terminated 3Unknown 2

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1CNS 1

Conditions

Neoplasms 1Brain Neoplasms 1

Interventions

Cisplatin 349Oxaliplatin 260Capecitabine 258Radiotherapy 238Gemcitabine 221Docetaxel 221Carboplatin 220Drug Therapy 216Cyclophosphamide 216apatinib 200Paclitaxel 199Bevacizumab 194camrelizumab 189Fluorouracil 187sintilimab 131Irinotecan 125Blood Specimen Collection 124Dexamethasone 122Etoposide 118toripalimab 115Surgical Procedures, Operative 115Radiosurgery 114pembrolizumab 111Pemetrexed 108anlotinib 105S 1 (combination) 105Leucovorin 101Surveys and Questionnaires 98tislelizumab 96Doxorubicin 96

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × OTHER × Memantine × Clear all
NCT05834231 2023-04-28

Efficacy of Memantine in Prevention of Oxaliplatin-induced Peripheral Neurotoxicity

Mansoura University

Phase 1/2 Unknown
60 enrolled
Tumor-Agnostic

Neoplasms

NCT04801342 2021-03-17

Neurocognitive Outcome of Bilateral or Unilateral Hippocampal Avoidance WBRT With Memantine for Brain Metastases

National Taiwan University Hospital

Phase 2 Unknown
72 enrolled
CNS

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡